Sullivan and collaborators hypothesize that alteration in expression in ghrelin receptor observed in diabetic cardiomyopathy could be a consequence of upregulation of inflammatory factors such as IL-1β, IL-6 [33]. This evidence concerns the gene IL1B and diabetic cardiomyopathy.